Regulation - Servier

Filter

Current filters:

Servier

Popular Filters

Ivabradine and CV events in angina patients under review in Australia

Ivabradine and CV events in angina patients under review in Australia

23-06-2014

Australian pharma regulator the Therapeutic Goods Administration (TGA) is reviewing new information regarding…

AustraliaCardio-vascularCoralanivabradinePharmaceuticalRegulationServier

EMA pharmacovigilance unit calls for suspension of Protelos/Osseor

EMA pharmacovigilance unit calls for suspension of Protelos/Osseor

10-01-2014

The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has recommended…

Anti-Arthritics/RheumaticsEuropeOsseorPharmaceuticalProtelosRegulationServierWomen's Health

EMA Committee calls for curbs on Protelos/Osseor, tetrazepam suspension

12-04-2013

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) has recommended restrictions…

BayerDiane-35EuropeOsseorPharmaceuticalProtelosRegulationServiertetrazepam

Four new safety referrals evaluated as impact of new pharmacovigilance legislation kicks in, says EMA

02-12-2012

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) held its fifth meeting…

diacerinEuropeGenericsPharmaceuticalRegulationServierVectarian

UK NICE draft guidance backs Servier's Procoralan for chronic heart failure

06-08-2012

The UK's drugs watchdog the National Institute for Health and Clinical Excellence (NICE), in draft guidance…

Cardio-vascularEuropePharmaceuticalPricingProcoralanRegulationServier

EMA calls for curbs on trimetazidine-containing and tolperisone medicines

24-06-2012

The European Medicines Agency on Friday recommended restricting the use of trimetazidine-containing medicines…

Cardio-vascularEuropeNeurologicalPharmaceuticalRegulationServiertolperisonetrimetazidineVestrel

Move towards better detection and EU-wide withdrawal of dangerous medicines

10-05-2012

The adverse effects of medicinal products will be better monitored in future, to prevent the recurrence…

EuropePharmaceuticalPoliticsRegulationServier

EMA backs Protelos and Osseor, but with warnings

19-03-2012

The European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) has finalized a review…

Anti-Arthritics/RheumaticsEuropeOsseorPharmaceuticalProtelosRegulationServier

EC closes procedural case against Servier

29-01-2012

The European Commission said last Friday that it has closed an investigation into Fremch independent…

EuropeGenericsMarkets & MarketingPharmaceuticalRegulationServier

Company Spotlight

ImmunoGen

ImmunoGen

Back to top